ScholarIQanswers from OpenAlex & ORCID
B.-C. Liao
ResearcherPublications, citations & collaboration network
B.-C. Liao is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does B.-C. Liao have?
ScholarIQindexed works
B.-C. Liao has 3 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does B.-C. Liao have?
ScholarIQcitation count
B.-C. Liao has 6 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of B.-C. Liao?
ScholarIQh-index
B.-C. Liao has an h-index of 2 in OpenAlex.
What is the i10-index of B.-C. Liao?
ScholarIQi10-index
B.-C. Liao has an i10-index of 0 in OpenAlex.
What is the OpenAlex record for B.-C. Liao?
ScholarIQopenalex
The OpenAlex for B.-C. Liao is on the source record.
What are the most-cited papers on B.-C. Liao?
ScholarIQmost cited works
P4.07D.04 Trofuse-019: A Phase 3 Study of Adjuvant Pembrolizumab with or without Sac-TMTfor Resectable Stage II-IIIB (N2) NSCLC
Jang‐Ming Lee, B.-C. Liao, Jonathan Spicer, T. Newsom-Davis, RosalineChung-Yee Hui, Yiquan Xu, A. Song, Ayman Samkari, M. Hochmair
EP08.02-127 Resistance Mechanisms to Osimertinib in Advanced EGFR-mutated NSCLC: A Single Institution Prospective Cohort Study
B.-C. Liao, C.-Y. Yang, T.-H. Tsai, W.-Y. Liao, K.-Y. Chen, C.-C. Ho, J.-Y. Shih, C.-J. Yu, J.C.-H. Yang
Acalabrutinib versus venetoclax plus obinutuzumab in treatment-naive chronic lymphocytic leukemia: A real-world propensity score-matched study
Chieh‐Lin Jerry Teng, Yu-Min Liao, B.-C. Liao